Human Genome Epidemiology Literature Finder
Records 1 - 8 (of 8 Records) |
Query Trace: Syndrome and ERCC1[original query] |
---|
Influence of genetic markers on survival in non-small cell lung cancer. Drugs of today (Barcelona, Spain : 1998) 2003 Oct 39 (10): 775-86. Rosell Rafael, Taron Miquel, Camps Carlos, López-Vivanco Guiller |
Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine/cisplatin-treated advanced non-small-cell lung cancer patients. Clinical lung cancer 2003 Jan 4 (4): 237-41. Camps Carlos, Sarries Carmen, Roig Bárbara, Sanchez José Javier, Queralt Cristina, Sancho Eva, Martinez Natividad, Tarón Miguel, Rosell Rafa |
Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer. Cancer 2012 Feb 118 (3): 689-97. Fleming Nicole D, Agadjanian Hasmik, Nassanian Hoorig, Miller Carl W, Orsulic Sandra, Karlan Beth Y, Walsh Christine |
[Study of the correlation between the colorectal cancer Chinese medicine syndrome types and (excision repair cross-complementing 1, ERCC1) gene polymorphisms]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban 2012 May 32 (5): 628-32. Cui Tong-Jian, Chen Yi-Qian, Dai Yong-M |
[Validation of genetic polymorphisms associated to the toxicity of chemotherapy in colorectal cancer patients]. Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria 0 38 (4): 283-90. Cortejoso L, García M I, García-Alfonso P, Grávalos C, Robles L, González-Haba E, Sanjurjo M, López-Fernández L |
Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy. Cancer chemotherapy and pharmacology 2015 Apr 75 (4): 763-72. Joerger M, Huitema A D R, Boot H, Cats A, Doodeman V D, Smits P H M, Vainchtein L, Rosing H, Meijerman I, Zueger M, Meulendijks D, Cerny T D, Beijnen J H, Schellens J H |
Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial. Annals of oncology : official journal of the European Society for Medical Oncology 2017 Nov . Abad A, Martínez-Balibrea E, Viéitez J M, Alonso-Orduña V, García Alfonso P, Manzano J L, Massutí B, Benavides M, Carrato A, Zanui M, Gallego J, Grávalos C, Conde V, Provencio M, Valladares-Ayerbes M, Salazar R, Sastre J, Montagut C, Rivera F, Aranda |
Somatic variants of potential clinical significance in the tumors of BRCA phenocopies. Hereditary cancer in clinical practice 2019 7 17 21. Buckingham Lela, Mitchell Rachel, Maienschein-Cline Mark, Green Stefan, Hu Vincent Hong, Cobleigh Melody, Rotmensch Jacob, Burgess Kelly, Usha Lyd |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: